Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma

BACKGROUND: The purpose of this study (GSK ADA111194) was to compare asthma-related health care utilization and costs associated with fluticasone propionate (an inhaled corticosteroid [ICS]) and salmeterol (a long-acting beta-agonist) in a single inhalation device (fluticasone propionate-salmeterol)...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Stanford, Richard H, Shah, Manan, D’Souza, Anna O
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2012
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3536350/
https://ncbi.nlm.nih.gov/pubmed/23300347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S34582
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi